Literature DB >> 14662341

In vivo and in vitro differentiation of myocytes from human bone marrow-derived multipotent progenitor cells.

Yukari Muguruma1, Morayma Reyes, Yoshihiko Nakamura, Tadayuki Sato, Hideyuki Matsuzawa, Hiroko Miyatake, Akira Akatsuka, Johbu Itoh, Takashi Yahata, Kiyoshi Ando, Shunichi Kato, Tomomitsu Hotta.   

Abstract

OBJECTIVE: Recent studies have shown that bone marrow (BM) contains cells capable of differentiating into myocytes in vivo. However, addition of demethylation drugs has been necessary to induce myocyte differentiation from BM cells in vitro, and precise mechanisms of BM cells' conversion to myocytes and the origin of those cells have not been established. We investigated the expression of myogenic markers during differentiation and maturation of myocytes from BM-derived multipotent adult progenitor cells (MAPC) under physiological culture condition.
MATERIALS AND METHODS: Frozen BM samples from 21 healthy donors were used as a source of MAPC. To induce myocyte differentiation MAPC was cultured in the presence of 5% FCS, VEGF, bFGF, and IGF-1, and the expressions of myocyte markers were examined at various time points. We also investigated engraftment and differentiation of MAPC-derived myocytes in vivo.
RESULTS: Frozen BM-derived MAPC, cultured under the physiological myogenic condition, demonstrated spatial expression patterns of several myocyte markers similar to that of authentic myocyte differentiation. When injected into murine muscles, MAPC treated with the myogenic condition engrafted and differentiated into myocyte marker-positive cells and myotubes in vivo.
CONCLUSION: For the first time, we were able to induce myocyte formation from BM cells under the physiological condition in vitro and demonstrated that treating cells with this condition prior to intramuscular injection increased efficiency of engraftment and differentiation in vivo.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662341     DOI: 10.1016/j.exphem.2003.09.003

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  25 in total

1.  Effects of insulin-like growth factor-1 on the properties of mesenchymal stem cells in vitro.

Authors:  Yu-li Huang; Ruo-feng Qiu; Wei-yi Mai; Jian Kuang; Xiao-yan Cai; Yu-gang Dong; Yun-zhao Hu; Yuan-bin Song; An-ping Cai; Zhi-gao Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2012-01       Impact factor: 3.066

2.  Human adipose tissue derived mesenchymal stem cells are resistant to several chemotherapeutic agents.

Authors:  Wei Liang; Hailong Xia; Jing Li; Robert Chunhua Zhao
Journal:  Cytotechnology       Date:  2011-07-15       Impact factor: 2.058

3.  Establishment of a xenograft model of human myelodysplastic syndromes.

Authors:  Yukari Muguruma; Hiromichi Matsushita; Takashi Yahata; Shizu Yumino; Yumiko Tanaka; Hayato Miyachi; Yoshiaki Ogawa; Hiroshi Kawada; Mamoru Ito; Kiyoshi Ando
Journal:  Haematologica       Date:  2010-12-29       Impact factor: 9.941

Review 4.  Strategies to improve regeneration of the soft palate muscles after cleft palate repair.

Authors:  Paola L Carvajal Monroy; Sander Grefte; Anne Marie Kuijpers-Jagtman; Frank A D T G Wagener; Johannes W Von den Hoff
Journal:  Tissue Eng Part B Rev       Date:  2012-07-19       Impact factor: 6.389

Review 5.  Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophy.

Authors:  Chad D Markert; Anthony Atala; Jennifer K Cann; George Christ; Mark Furth; Fabrisia Ambrosio; Martin K Childers
Journal:  PM R       Date:  2009-06       Impact factor: 2.298

Review 6.  The origin, molecular regulation and therapeutic potential of myogenic stem cell populations.

Authors:  A Otto; H Collins-Hooper; K Patel
Journal:  J Anat       Date:  2009-08-24       Impact factor: 2.610

7.  Hematopoietic cell transplantation directly into dystrophic muscle fails to reconstitute satellite cells and myofibers.

Authors:  Christian S Kuhr; Marilena Lupu; Rainer Storb
Journal:  Biol Blood Marrow Transplant       Date:  2007-06-18       Impact factor: 5.742

Review 8.  Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells.

Authors:  Sandra A Jacobs; Valerie D Roobrouck; Catherine M Verfaillie; Stefaan W Van Gool
Journal:  Immunol Cell Biol       Date:  2013-01       Impact factor: 5.126

9.  EF1alpha and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells.

Authors:  Kevin M Curtis; Lourdes A Gomez; Carmen Rios; Elisa Garbayo; Ami P Raval; Miguel A Perez-Pinzon; Paul C Schiller
Journal:  BMC Mol Biol       Date:  2010-08-17       Impact factor: 2.946

10.  Regenerative strategies for craniofacial disorders.

Authors:  Catharine B Garland; Jason H Pomerantz
Journal:  Front Physiol       Date:  2012-12-14       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.